Stereotaxis Stock Valuation

STXS -  USA Stock  

USD 1.99  0.11  5.24%

How much is Stereotaxis worth today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Stereotaxis, is its stock price multiplied by the total number of shares outstanding, calculating Stereotaxis' enterprise value requires a different approach. It uses Stereotaxis' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Stereotaxis Enterprise Value is relatively stable at the moment as compared to the past year. Stereotaxis reported last year Enterprise Value of 35.2 Million. As of 06/24/2022, Tangible Asset Value is likely to grow to about 21.5 M, while Free Cash Flow is likely to drop (2.6 M).
Stereotaxis has a current Real Value of $4.19 per share. The regular price of the company is $1.99. Based on Macroaxis valuation methodology, the company appears to be undervalued. Our model measures the value of Stereotaxis from inspecting the company fundamentals such as Return On Equity of (26.91) %, operating margin of (36.80) %, and Shares Outstanding of 74.58 M as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend buying undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Stereotaxis Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Stereotaxis's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Stereotaxis Most Recent Valuation Data

Price Book
Price Sales
-3.9 M
Fiscal Year End
Medical Instruments & Supplies
Enterprise Value
117.7 M
Today 1.99
Please note that Stereotaxis' price fluctuation is unstable at this time. Calculation of the real value of Stereotaxis is based on 3 months time horizon. Increasing Stereotaxis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Stereotaxis is useful when determining the fair value of the Stereotaxis stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Stereotaxis. Since Stereotaxis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stereotaxis Stock. However, Stereotaxis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Stereotaxis helps investors to forecast how Stereotaxis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stereotaxis more accurately as focusing exclusively on Stereotaxis' fundamentals will not take into account other important factors:
Estimates (2)
LowProjected EPSHigh
LowEstimated ValueHigh
LowNext ValueHigh
4 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Stereotaxis' intrinsic value based on its ongoing forecasts of Stereotaxis' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Stereotaxis' closest peers. When choosing an evaluation method for Stereotaxis, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Stereotaxis Investments

8.42 Million


Stereotaxis Valuation Drivers Correlation

Many accounts on the financial statements of Stereotaxis are highly interrelated and sometimes correlated. Consequently, when conducting Stereotaxis's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Stereotaxis
Click cells to compare fundamentals

Stereotaxis Valuation Trend

Knowing Stereotaxis' actual value is paramount for traders to make sound investment determinations. Stereotaxis' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Stereotaxis' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Stereotaxis' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Stereotaxis Market Cap

Stereotaxis is currently regarded as top stock in market capitalization category among related companies. Market capitalization of Medical Instruments & Supplies industry is at this time estimated at about 907.85 Million. Stereotaxis retains roughly 135.74 Million in market capitalization claiming about 15% of all equities under Medical Instruments & Supplies industry.
Capitalization  Workforce  Revenue  Valuation  Total debt

Stereotaxis Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Stereotaxis's current stock value. Our valuation model uses many indicators to compare Stereotaxis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stereotaxis competition to find correlations between indicators driving Stereotaxis's intrinsic value. More Info.
Stereotaxis is currently regarded as top stock in price to earning category among related companies. It is currently regarded as top stock in beta category among related companies totaling about  0.07  of Beta per Price to Earning. The ratio of Price to Earning to Beta for Stereotaxis is roughly  13.85 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Stereotaxis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Stereotaxis' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Stereotaxis' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Stereotaxis' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Stereotaxis and how it compares across the competition.

About Stereotaxis Valuation

The equity valuation mechanism determines the current worth of Stereotaxis on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Stereotaxis. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Stereotaxis based exclusively on its fundamental and basic technical indicators. By analyzing Stereotaxis's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Stereotaxis's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Stereotaxis. We calculate exposure to Stereotaxis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Stereotaxis's related companies.
Last ReportedProjected for 2022
Gross Profit24.5 M21.8 M
Profit Margin(22.46) (24.24) 
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri. Stereotaxis operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 130 people.

Stereotaxis Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Stereotaxis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio3.33
Revenue Growth20.70%
Enterprise Value To Ebitda-12.48
Enterprise Value To Revenue4.56

Stereotaxis Current Valuation Indicators

Valuation refers to the process of determining the present value of Stereotaxis and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Stereotaxis we look at many different elements of the entity such as Stereotaxis's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Stereotaxis' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Stereotaxis' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Stereotaxis, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Stereotaxis' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Stereotaxis' worth.
Additionally, take a look at World Market Map. Note that the Stereotaxis information on this page should be used as a complementary analysis to other Stereotaxis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Stereotaxis Stock analysis

When running Stereotaxis price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Stereotaxis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stereotaxis. If investors know Stereotaxis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stereotaxis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
156.8 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Stereotaxis is measured differently than its book value, which is the value of Stereotaxis that is recorded on the company's balance sheet. Investors also form their own opinion of Stereotaxis' value that differs from its market value or its book value, called intrinsic value, which is Stereotaxis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stereotaxis' market value can be influenced by many factors that don't directly affect Stereotaxis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stereotaxis' value and its price as these two are different measures arrived at by different means. Investors typically determine Stereotaxis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stereotaxis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.